Kansas legislation · 2025-2026 Regular Session
Kansas HB2100: Establishing statewide standards governing the use of HIV post-exposure prophylaxis, permitting a pharmacist to initiate such medication to certain patients, providing civil liability protections to pharmacists who initiate prophylactic therapy to patients for post-exposure to human immunodeficiency virus
Status: In committee, April 10, 2026
What the bill says
An act concerning pharmacists and pharmacy; relating to HIV postexposure prophylaxis; requiring the state board of pharmacy to issue protocol for pharmacists to dispense post-exposure prophylaxis to certain individuals.
From the introduced text, January 27, 2025:
AN ACT concerning pharmacists and pharmacy; relating to HIV postexposure prophylaxis; requiring the state board of pharmacy to issue protocol for pharmacists to dispense post-exposure prophylaxis to certain individuals. Be it enacted by the Legislature of the State of Kansas: Section 1. (a) As used in this section: (1) "HIV" means the human immunodeficiency virus. (2) "Patient" means an individual believed to have been exposed to HIV. (3) "Post-exposure prophylasis" means a drug or drug combination that meets the clinical eligibility recommendations of the United States centers for disease control and prevention guidelines for antiretroviral treatment following exposure to HIV. (b) (1) The state board of pharmacy shall issue a statewide postexposure prophylaxis protocol for individuals who have been exposed to HIV that establishes requirements for a licensed pharmacist to initiate prophylactic therapy to a patient pursuant to this section. The protocol for post-exposure to HIV shall include procedures to ensure accurate recordkeeping and the education of the patient to whom post-exposure prophylaxis is initiated, including, but not limited to, the importance of receiving post-exposure prophylaxis as soon as possible after exposure, safe administration of post-exposure prophylaxis and potential contraindications, side effects or adverse events that may occur as a result of such medication, advising the patient to whom post-exposure prophylaxis is initiated to seek follow-up care from a physician …
Sponsors
- Brandon Woodard (D) · primary sponsor
Latest actions
- : Died in Committee
- : Withdrawn from House Committee on Insurance ; Rereferred to House Committee on Insurance
- : Withdrawn from House Committee on Health and Human Services ; Rereferred to House Committee on Health and Human Services
- : Withdrawn from House Committee on Insurance ; Referred to House Committee on Insurance
- : Withdrawn from House Committee on Health and Human Services ; Rereferred to House Committee on Health and Human Services
- : Withdrawn from House Committee on Insurance ; Referred to House Committee on Insurance
- : Referred to House Committee on Health and Human Services
- : Introduced
Subjects: Pharmacists and Pharmacy, Boards, Commissions and Task Forces
Common questions
- What is HB2100?
- HB2100 is a bill in the Kansas Legislature (2025-2026 Regular Session): Establishing statewide standards governing the use of HIV post-exposure prophylaxis, permitting a pharmacist to initiate such medication to certain patients, providing civil liability protections to pharmacists who initiate prophylactic therapy to patients for post-exposure to human immunodeficiency virus.
- What does HB2100 do?
- In its own words: An act concerning pharmacists and pharmacy; relating to HIV postexposure prophylaxis; requiring the state board of pharmacy to issue protocol for pharmacists to dispense post-exposure prophylaxis to certain individuals.
- What is the status of HB2100?
- In committee as of April 10, 2026. Latest action: Died in Committee (April 10, 2026).
- Who sponsored HB2100?
- Brandon Woodard (D).
- Where is the official record for HB2100?
- On the Kansas Legislature website: https://kslegislature.gov/li/b2025_26/measures/hb2100/
Source: official Kansas record. Tracked by Delilah, AI for legislation across all 50 states and Congress.